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Cystic ﬁbrosis (CF) is a genetically inherited autosomal recessive disease characterized by dehydration of
the airway surface liquid and impaired mucociliary clearance leading to chronic respiratory infections,
bronchiectasis and ultimately death from respiratory causes. Common pulmonary related complications
resulting from bronchiectasis include pneumothorax and hemoptysis. A rare, seldom reported compli-
cation is acute pericarditis complicating cystic ﬁbrosis. Our review of the literature identiﬁed only
a single case of culture-proven purulent pericarditis attributed to Pseudomonas aeruginosa in a patient
receiving systemic corticosteroids. A second reported case of acute pericarditis in a CF patient was
attributed to Mycoplasma pneumoniae which is a known cause of infectious-related pericarditis inde-
pendent of CF. Both cases required open pericardial drainage with 1 fatality. Here we present a case of
cardiac tamponade from a ﬁbrinous pericardial effusion in a 21-year-old female as a complication of CF
related parenchymal lung disease. To our knowledge, this is the ﬁrst reported case of a non-infectious
parapneumonic pericardial effusion causing near fatal cardiac tamponade as a complication of CF lung
disease.
Published by Elsevier Ltd.1. Introduction
Cystic ﬁbrosis (CF) is a genetically inherited autosomal recessive
disease characterized by dehydration of the airway surface liquid
and impaired mucociliary clearance leading to chronic respiratory
infections, bronchiectasis and ultimately death from respiratory
causes.1 Previously a disease of predominantly children, the current
median expected survival age has reached 36 years. The 2006 Cystic
Fibrosis Foundation annual data report lists over 24,000 patients
living with the disease, and 44.6% are over the age of 18.2 Common
non-pulmonary related complications of the disease include dia-
betes, pancreatic insufﬁciency, bone disease and liver disease.
Common pulmonary related complications resulting from bron-
chiectasis include pneumothorax and hemoptysis. A rare, seldom
reported complication is acute pericarditis complicating cysticX-ray; CT, computed tomog-
me in 1st second; FVC, forced
ctate dehydrogenase; MICU,
: þ1 717 531 5785.
.F. Betancourt), mikebenning
.edu (R.L. Vender), jting@hmc.ﬁbrosis. Here we present a case of pericarditis causing signiﬁcant
hemodynamic compromise, or cardiac tamponade, in a 21-year-old
female as a complication of CF related parenchymal lung disease.2. Case report
A 21-year-old female with CF diagnosed within two years of life
with 1 identiﬁed copy of the delta F 508 mutation presented to our
institution for evaluation and management of progressive
malnutrition with a weight of 39 kg, poor appetite, fatigue, malaise
of months duration and recent onset of fever but only mild
dyspnea and minimal sputum production. She was admitted to the
hospital for aggressive nutritional repletion and gastrostomy tube
placement.
Her outpatient respiratory directed regimen consisted of high
frequency chest wall oscillator for airway clearance, inhaled DNase
(Pulmozyme), inhaled colistin, and bronchodilators. Her sputum
cultures in the past had shown Stenotrophomonas maltophilia
(susceptible to levoﬂoxacin and trimethoprim-sulfamethoxazole,
resistant to ticarcillin-clavulanate), Staphylococcus aureus (sensitive
to oxacillin), Pseudomonas ﬂuorescens putida (susceptible to
aztreonam and ciproﬂoxacin, resistant to ticarcillin-clavulanate),
and Aspergillus fumigatus. Her most recent forced vital capacity
Fig. 2. Computed tomography demonstrating severe diffuse bronchiectasis.
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1st second (FEV1) was 2.01 L, 69% of predicted, FEV1/FVC ratio of
75%, and forced expiratory ﬂow (FEF) 25–75% of 1.60 L per second,
46% of predicted.
She was admitted to the hospital and based upon available in
vitro antibiotic susceptibility testing; intravenous ticarcillin-clav-
ulanate, aztreonam and levoﬂoxacin antibiotic therapywere begun.
She was intermittently febrile but blood/urine cultures were
negative. Admission WBC count was 12,100 cells/mL and chest
radiograph disclosed chronic changes of cystic ﬁbrosis with bilat-
eral bronchiectasis, areas of mucus plugging and peribronchial
thickening but normal cardiothoracic ratio (Fig. 1).
On hospital day # 6, the patient underwent a gastrostomy tube
placement to improve her nutritional status and her goal of tube
feeds was achieved without difﬁculty. On hospital day # 10, she
complained of chest pain, pleuritic in nature, substernal in location,
which resolved following administration of oral oxycodone and
intravenous morphine. Non-contrast computed tomography (CT)
scan of the chest was completed and showed persistent air-space
disease adjacent to the heart, worsened since her previous CT done
eight months before current hospitalization (Fig. 2). Notably, there
was a small pericardial effusion (Fig. 3). Sputum cultures from this
admission only revealed S. aureus (sensitive to oxacillin) and
Enterobacter asburiae (susceptible to all antibiotics tested).
On hospital day # 15, the patient developed a new episode of
chest pain, this time it was accompanied by a blood pressure of
78/52 mmHg and a heart rate of 131 beats per minute. Intravenous
tobramycin was added to the antibiotic regimen. Emergent trans-
thoracic echocardiogram revealed low normal left ventricular size
and preserved left ventricular ejection fraction with a small,
compressed right ventricle. A moderate circumferential pericardial
effusion with ﬁbrinous stranding was noted with two-dimensional
evidence of hemodynamic compromise including diastolic right
atrial and right ventricular collapse (Figs. 4 and 5,). The patient was
transferred to the Medical Intensive Care Unit (MICU) and cardio-
thoracic surgery service was consulted. Blood work performed
upon MICU presentation disclosed alanine aminotransferaseFig. 1. Admission CXR demonstrating bilateral bronchiectasis, areas of mucus plugging
and peribronchial thickening.>5000 IU/L, aspartate aminotransferase >7500 IU/L, blood urea
nitrogen of 45 mg/dl and serum creatinine of 1.21 mg/dl which
peaked at a value of 1.38 mg/dl. She was taken to the operating
room and a pericardial window and drain were placed. The peri-
cardium was found to be grossly thickened, and upon its entrance
500 cc of serosanguinous ﬂuid under pressure was immediately
evacuated. The patient’s blood pressure markedly increased to
105/63 mmHg and her tachycardia resolved. Pericardial ﬂuid
bacterial, acid fast bacilli (AFB) and fungus cultures were negative.
Cytology of ﬂuid was negative for malignant cells. Pericardial
biopsy revealed acute inﬂammation and proteinaceous debris. The
specimen consisted of loose ﬁbrovascular tissue, much of whichFig. 3. Computed tomography demonstrating bronchiectasis and air-space disease in
contiguous nature to pericardium in association with relatively small pericardial
effusion.
Fig. 4. Apical four-chamber 2-dimensional still image revealing circumferential peri-
cardial effusion with ﬁbrinous stranding. Collapse of the right atrial wall is noted.
Fig. 6. Apical four-chamber 2-dimensional still image after pericardial drainage and
window placement reveals no pericardial effusion and decompression of the left and
right ventricle.
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admixed with neutrophils, and the surface of the mesothelium
contained ﬁbrin admixed with neutrophils. Transthoracic echo-
cardiogramwas performed 5 days after the pericardial window and
drain procedure; there was no pericardial effusion and the right
ventricle was markedly decompressed (Fig. 6). All laboratory values
returned to normal prior to discharge. The patient was discharged
from the Hospital in stable condition with follow up in the Cystic
Fibrosis outpatient clinic. Acute and convalescent viral serological
testing was not performed during hospital admission. Five months
after the operative procedure, blood serological studies were
obtained to potentially identify causative infectious agents. Anti-
body testing for Cytomegalovirus (CMV), Coxsackie virus, Epstein–
Barr virus (EBV), Parvovirus B19, andMycoplasma pneumoniaewere
either negative or non-reactive. Antibody serology directed against
Adenovirus was reported positive at titer 1:16. Anti-nuclear anti-
body (ANA) testing was negative.3. Discussion
Cystic ﬁbrosis is characterized by persistent sustained high
level endobronchial airways infection and suppuration,1 yet inva-
sive infections with septicemia and distant organ dissemination
are rare in CF patients. Just as importantly, despite the high levels
of intrathoracic infection and inﬂammation, invasion or damage toFig. 5. Apical short axis view of the left and right ventricle (as labeled) revealed the
ﬁbrinous pericardial effusion and compression of the right ventricle.contiguous anatomic structures is also rare. Our review of the
literature identiﬁed only a single case of culture-proven purulent
pericarditis attributed to Pseudomonas aeruginosa in a patient
receiving systemic corticosteroids.3 A second reported case of
acute pericarditis in a CF patient was attributed to M. pneumoniae
which is a known cause of infectious-related pericarditis inde-
pendent of CF.4 Both cases required open pericardial drainage with
1 fatality. Although uncommon, purulent pericarditis is associated
with a relatively high mortality and is thought most commonly to
result from adjacent spread from a contiguous intrathoracic
infection or blood-borne hematogenous dissemination most
commonly due to Streptococcus pneumoniae.5 Purulent pericarditis
is often fatal if untreated. But even with therapy, mortality is 40%.6
However, in relation to our reported case, the absence of gross
purulence at the time of open surgery and culture negativity of
drained pericardial ﬂuid makes a purulent infectious cause of this
patient’s clinical course less likely. In addition, the negative or non-
reactive convalescent serological testing for CMV, Coxsackie virus,
EBV, Parvovirus B19, and M. pneumoniae makes the causative role
for these various infective agents unlikely. Adenovirus serology was
positive at titer 1:16. Even though Adenovirus pericarditis is
a commonly reported cause of acute pericarditis, the facts that the
titer of 1:16 was indeterminate and the more common occurrence
of Adenovirus infection in children makes the potential etiology of
Adenovirus as causative agent less likely also.7 The explanation for
this patient’s pericardial effusion and resulting cardiac tamponade
is most analogous to a parapneumonic pleural effusion which is
a known non-infected pleural complication of a contiguous infec-
tious pneumonia.8
A ‘‘parapneumonic pleural effusion’’ is an accumulation of
exudative non-viscous pleural ﬂuid associated with an ipsilateral
pulmonary infection characterized by low white blood cell count
and lactate dehydrogenase (LDH) level but normal pH and glucose
concentrations.9,10 The ﬂuid accumulation is due to increased
pulmonary interstitial ﬂuid traversing the pleura to enter the
pleural space but some is also due to increased permeability of the
capillaries in the pleural space.11 ‘‘Uncomplicated parapneumonic
effusions’’ are not infected and do not usually need tube thor-
acostomy. Antibiotic treatment alone may sufﬁce.10
In one published case, a patient who developed pneumoniawith
a parapneumonic effusion subsequently developed a pericardial
effusion due to methicillin-resistant S. aureus. The authors theo-
rized that during the exudative phase of a pleural effusion, pleural
M.F. Betancourt et al. / Respiratory Medicine CME 3 (2010) 156–159 159and pericardial effusions can develop if these compartments are
adjacent to the pneumonic process with resultant increased
microvascular permeability because the pleural and pericardial
surfaces separating these compartments are juxtaposed and have
porous connections.12
From the case presented here, biochemical analysis of pericar-
dial ﬂuid was not obtained at the time of open pericardial drainage.
However, all cultures failed to identify any infecting pathogen. To
our knowledge, this is the ﬁrst reported case of a non-infectious
parapneumonic pericardial effusion causing near fatal cardiac
tamponade as a complication of CF lung disease.
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